Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001774690-26-000004

Chief Financial Officer acquired 14,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Leggett Thomas · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-15 Exercise or conversion : show line 1 in the form +14,750 14,750 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-15 Exercise or conversion : show line 2 in the form Restricted Stock Units −14,750 44,250 D
Loading xslF345X05/form4-03172026_090359.xml…